Technology

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

Published

2 years ago

September 3, 2024

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers an affordable entry point into routine, high-performance single cell analysis.

“Chromium Xo is the latest in a series of 10x innovations intended to democratize single cell analysis because we never want researchers to have to settle for anything less than the best,” said Ben Hindson, Chief Scientific Officer and Co-founder. “With Chromium Xo, we’re not just lowering the cost barrier; we’re empowering more researchers to achieve high-quality, repeatable results necessary for meaningful scientific breakthroughs.”

Chromium Xo is 10x Genomics’ most affordable single cell instrument, delivering the high-quality data, superior reproducibility and ease of use that the company’s instrument-powered workflows are known for, at a U.S. list price of $25,000.

Chromium Xo is specifically designed to run 10x Genomics’ industry-leading GEM-X 3′ assay, which provides up to 80% cell capture and more than 40% higher gene sensitivity compared to alternative non-10x methods. GEM-X technology also enables researchers to generate more usable reads to detect more genes with less sequencing, potentially saving more than 50% on sequencing costs compared to non-10x methods.

In addition, there is a path for researchers to seamlessly upgrade to Chromium X to access the full breadth of the company’s single cell portfolio, including assays for FFPE samples and immune profiling.

With features like automation to partition hundreds of thousands of cells in minutes and an intuitive push-button interface for efficient cell processing, Chromium instruments remove many of the challenges and inconsistencies of manual, instrument-less workflows. The instrument-powered Chromium platform enables high data quality and twice the sample recovery as manual methods. In addition, Chromium instruments streamline the workflow, improve scalability and enable superior reproducibility, resulting in less hands-on time, lower labor and experimental costs and faster time to results compared to alternative single cell workflows.

Added Hindson, “Our ultimate goal is to enable high-performance single cell analysis for $100 per sample. With Chromium Xo and what’s planned in our pipeline, we are continuing to drive our Chromium technology in that direction so more researchers can rely on these methods more often.”

Chromium Xo is now shipping globally.

About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the “safe harbor” provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “see,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding 10x Genomics, Inc.’s (“10x Genomics”) and others’ product launches, performance, configuration, costs, capabilities, requirements, workflows, adoption and pipeline. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics’ financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the “SEC”) from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics’ views as of any date subsequent to the date of this press release.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-unveils-chromium-xo-a-low-cost-instrument-to-expand-access-to-high-performance-single-cell-research-302237175.html

SOURCE 10x Genomics, Inc.

Technology

Greenzie releases 2025 Annual Safety Report, documenting multi-year safety performance at commercial scale

Published

2 hours ago

April 23, 2026

The data shows zero lost-time injuries, zero OSHA medical attentions and zero human near-misses across real-world operation

ATLANTA, April 23, 2026 /PRNewswire/ — Greenzie, the technology platform powering commercial autonomy across multiple OEMs, today shared multi-year safety data from real-world commercial operation, documenting more than 150,000 autonomous miles with zero lost-time injuries, zero OSHA medical attentions and zero human near-misses. The data is published in Greenzie’s 2025 Annual Safety Report, available at greenzie.com/safety.

The report is based on extensive operational data spanning more than 5.4 billion square feet of turf mowed, 68,000+ hours of autonomous mowing and more than 50,000 operator days, the equivalent of 265 mowing seasons.

“Greenzie is helping define safety in autonomous landscape operations, and transparency is a critical part of that,” said Steve Bush, chief operating officer of Greenzie. “These results show that commercial autonomy is operating safely at meaningful scale in the field. Transparency matters because as this category matures, real-world data helps build confidence in what responsible deployment looks like.”

The report’s findings are particularly significant in the context of the U.S. landscaping industry, which employs roughly 1.3 million workers and experiences a higher-than-average rate of workplace accidents compared to other fields. Greenzie’s multi-year operating data shows that autonomy is not theoretical; it is already being deployed consistently and performing safely at scale.

“Greenzie Powered Autonomy™ has been validated through years of sustained use in the field,” Bush said. “That level of real-world performance reinforces both the reliability of our platform and the broader readiness of commercial autonomy.”

Greenzie attributes this performance to a disciplined safety approach that includes robust perception, tested operating standards and continuous validation in real-world commercial environments.

For more information about Greenzie, visit greenzie.com.

About Greenzie

Founded in 2018, Greenzie is the technology platform powering commercial autonomy. Created to solve the landscape industry’s labor and productivity challenges, Greenzie works with leading equipment manufacturers to deliver the software, navigation and safety systems that enable mowing and other outdoor power equipment to operate autonomously in real-world commercial environments. Today, Greenzie’s platform is running on hundreds of machines in active use, helping manufacturers bring autonomy to market and allowing operators to get more done with limited labor—moving autonomy from early experimentation to everyday operations. For more information, visit greenzie.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/greenzie-releases-2025-annual-safety-report-documenting-multi-year-safety-performance-at-commercial-scale-302750335.html

SOURCE Greenzie

Technology

CGI renews global SAP S/4HANA operations and SAP BTP operations certifications, reinforcing its consistent, quality delivery at scale

Published

2 hours ago

April 23, 2026

Stock Market Symbols
GIB.A (TSX)
GIB (NYSE)
cgi.com/newsroom

MONTRÉAL, April 23, 2026 /CNW/ – CGI (NYSE: GIB) (TSX: GIB.A), one of the largest independent IT and business consulting services firms in the world, announced that it has achieved the following recertifications for its global operation capabilities:

SAP S/4HANA operations and works with RISE with SAP SAP BTP operations and works with RISE with SAP

These recertifications highlight CGI’s ability to deliver consistent, high-quality managed SAP services and operations across regions, including services aligned with RISE with SAP. CGI’s SAP-based services help clients reduce operational risk, improve performance and efficiency and scale transformation with greater predictability. This also builds on CGI’s SAP alliance relationship momentum, including its recent AWS SAP Competency Partner status which highlights CGI’s expertise in modernizing mission-critical SAP workloads with AI-enabled cloud solutions.

“Running SAP at enterprise scale requires a partner with proven capabilities, delivery discipline and the ability to innovate securely, including through the integration of AI to deliver tangible outcomes,” said Didier Thérond, President, CGI France operations, and Global Executive Sponsor for CGI’s partnership with SAP. “These global recertifications reinforce CGI’s end-to-end SAP capabilities, including AI-enabled services, helping clients operate mission-critical systems with confidence and advance their modernization and cloud strategies.”

“CGI remains a trusted partner in our SAP Operations Partner program, consistently demonstrating a structured and disciplined approach to certification,” said Rudolf Scheipers, VP, Head of SAP Operations Partner Certification, SAP Partner Innovation Lifecycle Services. “These recertifications highlight the company’s mature operating model and commitment to the high standards we expect globally, ensuring clients running SAP environments can rely on consistent, secure, and efficient operations.”

CGI’s global alliance strategy features partnerships with more than 150 technology companies and supports its local relationship model complemented by a global delivery network. Through its SAP alliance, CGI helps organizations accelerate innovation, deploy and manage SAP solutions globally, and deliver industry-specific business outcomes with rapid, scalable, and AI-enabled cloud and ERP services.

About CGI
Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 94,000 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2025 reported revenue is CA$15.91 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at cgi.com.

View original content:https://www.prnewswire.com/news-releases/cgi-renews-global-sap-s4hana-operations-and-sap-btp-operations-certifications-reinforcing-its-consistent-quality-delivery-at-scale-302750863.html

SOURCE CGI Inc.

Technology

Scholastic Corporation Announces Final Results of Modified Dutch Auction Tender Offer

Published

2 hours ago

April 23, 2026

NEW YORK, April 23, 2026 /PRNewswire/ — Scholastic Corporation (the “Company” or “Scholastic”) (Nasdaq: SCHL), the global children’s publishing, education and media company, today announced the final results of its “modified Dutch Auction” tender offer for shares of its common stock, which expired at 5:00 p.m., New York City time, on April 20, 2026.

Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, a total of 2,834,018 shares of Scholastic’s common stock, par value $0.01 per share (each share of Scholastic’s common stock, a “Share,” and collectively, “Shares”), were properly tendered and not properly withdrawn at or below the purchase price of $40.00 per Share, including 989,343 Shares that were tendered by notice of guaranteed delivery.

Scholastic has accepted for purchase a total of 2,834,018 Shares through the tender offer at a price of $40.00 per Share, for an aggregate cost of $113,360,720.00, excluding fees and expenses relating to the tender offer. The total of 2,834,018 Shares that Scholastic has accepted for purchase represents approximately 13.7% of the total number of Shares outstanding as of April 19, 2026.

J.P. Morgan Securities LLC served as the dealer manager for the tender offer. Georgeson LLC served as the information agent. Holders of common stock who have questions or need information about the tender offer may call Georgeson LLC at (866) 539-9980 (toll free). Banks and brokers may call Georgeson at (866) 539-9980 or J.P. Morgan Securities LLC at (877) 371-5947 (toll free).

About Scholastic

For more than 100 years, Scholastic Corporation (Nasdaq: SCHL) has been meeting children where they are – at school, at home and in their communities – by creating quality content and experiences, all beginning with literacy. Scholastic delivers stories, characters, and learning moments that empower all kids to become lifelong readers and learners through bestselling children’s books, literacy- and knowledge-building resources for schools including classroom magazines, and award-winning, entertaining children’s media. As the world’s largest publisher and distributor of children’s books through school-based book clubs and book fairs, classroom libraries, school and public libraries, retail, and online, and with a global reach into more than 135 countries, Scholastic encourages the personal and intellectual growth of all children, while nurturing a lifelong relationship with reading, themselves, and the world around them. Learn more at www.scholastic.com.

Forward-Looking Statements

This news release contains certain forward-looking statements. Such forward-looking statements are subject to various risks and uncertainties, including the conditions of the children’s book and educational materials markets generally and acceptance of the Company’s products within those markets, and other risks and factors identified from time to time in the Company’s filings with the Securities and Exchange Commission. Actual results could differ materially from those currently anticipated.

SCHL: Financial

View original content to download multimedia:https://www.prnewswire.com/news-releases/scholastic-corporation-announces-final-results-of-modified-dutch-auction-tender-offer-302751142.html

SOURCE Scholastic Corporation